Canada court rejects bid for generic Viagra
OTTAWA (Reuters) - The Federal Court of Canada rejected on Thursday a bid by generic drugmaker Novapharm Ltd to be allowed to market a generic version of Pfizer Inc's erectile dysfunction drug Viagra.
The court said Novapharm should not be allowed to introduce a generic version until Pfizer's Canadian patent expires in 2014. The court rejected Novapharm's allegation that the patent is invalid.
Novapharm is part of Teva Pharmaceutical Industries Ltd
© Thomson Reuters 2009 All rights reserved
Finding the profit prescription
Pharmaceutical companies are striking mega deals, diversifying and cutting costs but Wall Street skepticism persists in many corners of the healthcare industry. Full Coverage
Chavez, troops to prepare for war